Abstract
We have previously reported suggestive linkage of type 2 diabetes mellitus to chromosome 10q1. We genotyped 228 microsatellite markers in Icelandic individuals with type 2 diabetes and controls throughout a 10.5-Mb interval on 10q. A microsatellite, DG10S478, within intron 3 of the transcription factor 7–like 2 gene (TCF7L2; formerly TCF4) was associated with type 2 diabetes (P = 2.1 × 10−9). This was replicated in a Danish cohort (P = 4.8 × 10−3) and in a US cohort (P = 3.3 × 10−9). Compared with non-carriers, heterozygous and homozygous carriers of the at-risk alleles (38% and 7% of the population, respectively) have relative risks of 1.45 and 2.41. This corresponds to a population attributable risk of 21%. The TCF7L2 gene product is a high mobility group box–containing transcription factor previously implicated in blood glucose homeostasis. It is thought to act through regulation of proglucagon gene expression in enteroendocrine cells via the Wnt signaling pathway2.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Reynisdottir, I. et al. Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2. Am. J. Hum. Genet. 73, 323–335 (2003).
Yi, F., Brubaker, P.L. & Jin, T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J. Biol. Chem. 280, 1457–1464 (2005).
Zimmet, P., Alberti, K.G. & Shaw, J. Global and societal implications of the diabetes epidemic. Nature 414, 782–787 (2001).
Rich, S.S. Mapping genes in diabetes. Genetic epidemiological perspective. Diabetes 39, 1315–1319 (1990).
Altshuler, D. et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26, 76–80 (2000).
Horikawa, Y. et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26, 163–175 (2000).
Gloyn, A.L. et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52, 568–572 (2003).
Duggirala, R. et al. Linkage of type 2 diabetes mellitus and of age at onset to a genetic location on chromosome 10q in Mexican Americans. Am. J. Hum. Genet. 64, 1127–1140 (1999).
Falk, C.T. & Rubinstein, P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann. Hum. Genet. 51, 227–233 (1987).
The International HapMap Consortium. The International HapMap Project. Nature 426, 789–796 (2003).
Mantel, N. & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22, 719–748 (1959).
Kong, A. & Cox, N.J. Allele-sharing models: LOD scores and accurate linkage tests. Am. J. Hum. Genet. 61, 1179–1188 (1997).
Prunier, C., Hocevar, B.A. & Howe, P.H. Wnt signaling: physiology and pathology. Growth Factors 22, 141–150 (2004).
Huelsken, J. & Birchmeier, W. New aspects of Wnt signaling pathways in higher vertebrates. Curr. Opin. Genet. Dev. 11, 547–553 (2001).
Nelson, W.J. & Nusse, R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303, 1483–1487 (2004).
Duval, A. et al. The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Res. 60, 3872–3879 (2000).
Fajans, S.S., Bell, G.I. & Polonsky, K.S. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med. 345, 971–980 (2001).
Wolfrum, C., Asilmaz, E., Luca, E., Friedman, J.M. & Stoffel, M. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432, 1027–1032 (2004).
Nakae, J. et al. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat. Genet. 32, 245–253 (2002).
Noble, J.A. et al. A polymorphism in the TCF7 gene, C883A, is associated with type 1 diabetes. Diabetes 52, 1579–1582 (2003).
Wong, N.A. & Pignatelli, M. Beta-catenin–a linchpin in colorectal carcinogenesis? Am. J. Pathol. 160, 389–401 (2002).
Lepourcelet, M. et al. Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex. Cancer Cell 5, 91–102 (2004).
Korinek, V. et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 19, 379–383 (1998).
Tanko, L.B., Bagger, Y.Z., Nielsen, S.B. & Christiansen, C. Does serum cholesterol contribute to vertebral bone loss in postmenopausal women? Bone 32, 8–14 (2003).
Lewontin, R.C. The interaction of selection and linkage. II. Optimum models. Genetics 50, 757–782 (1964).
Acknowledgements
We thank the members of the International HapMap Consortium for providing valuable data which were crucial for parts of our analysis.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
S.F.A.G., G.T., I.R., A.M., J. Sainz, A. Helgason, H.S., V.E., A. Helgadottir, U.S., K.P.M., G.B.W., E.P., T.J., T.G., A.G., J. Saemundsdottir, U.T., J.R.G., A.K. and K.S. own stock or stock options in deCODE Genetics.
Supplementary information
Supplementary Figure 1
A phylogenetic network representing the genealogical relationships between haplotypes in the TCF7L2 gene. (PDF 544 kb)
Supplementary Table 1
Genotype summaries for DG10S478 and the five correlated SNPs for the cohorts from Iceland, Denmark and USA. (PDF 21 kb)
Supplementary Table 2
Correlation of five selected public SNPs from the CEPH Utah HapMap with composite allele X of microsatellite DG10S478 in the cohorts from Iceland, Denmark and USA. (PDF 66 kb)
Supplementary Table 3
Association of the at-risk alleles of the five selected SNPs and the composite allele X of the microsatellite DG10S478 to type 2 diabetes in Iceland, Denmark and USA. (PDF 45 kb)
Supplementary Table 4
Combined association of the at-risk alleles of the five selected SNPs and the composite allele X of microsatellite DG10X478 to type 2 diabetes in all three cohorts. (PDF 41 kb)
Supplementary Table 5
Age and BMI ranges for the cohorts from Iceland, Denmark and USA. (PDF 22 kb)
Supplementary Table 6
Association between copies of composite allele X of DG10S478 and covariates within affected and control individuals separately. (PDF 22 kb)
Rights and permissions
About this article
Cite this article
Grant, S., Thorleifsson, G., Reynisdottir, I. et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38, 320–323 (2006). https://doi.org/10.1038/ng1732
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng1732
This article is cited by
-
Non-canonical non-genomic morphogen signaling in anucleate platelets: a critical determinant of prothrombotic function in circulation
Cell Communication and Signaling (2024)
-
Association of Polymorphic Variants of TCF7L2 and PPARG Genes with Metabolic Markers in Patients with Early Disorders of Carbohydrate Metabolism
Bulletin of Experimental Biology and Medicine (2024)
-
Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia
CNS Drugs (2024)
-
Genomic data in the All of Us Research Program
Nature (2024)
-
Association between the MTNR1B, HHEX, SLC30A8, and TCF7L2 single nucleotide polymorphisms and cardiometabolic risk profile in a mixed ancestry South African population
Scientific Reports (2023)
